Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | -3.01% | 72.51 | 1.0% | $1888.07m | |
| AMGN | Amgen, Inc. | -2.43% | 197.81 | 1.3% | $881.42m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.71% | 496.65 | 2.6% | $848.08m | |
| BIIB | Biogen, Inc. | -7.31% | 293.27 | 1.5% | $703.75m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -5.24% | 225.48 | 1.9% | $557.47m | |
| MRNA | Moderna, Inc. | -0.94% | 29.67 | 0.0% | $530.64m | |
| ILMN | Illumina, Inc. | -6.10% | 256.46 | 3.5% | $443.43m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.16% | 89.93 | 2.0% | $286.49m | |
| A | Agilent Technologies, Inc. | -3.67% | 68.99 | 1.6% | $220.20m | |
| EXAS | EXACT Sciences Corp. | -3.66% | 55.88 | 21.0% | $187.28m | |
| INCY | Incyte Corp. | 1.30% | 74.18 | 2.5% | $178.88m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -1.08% | 83.59 | 4.3% | $164.58m | |
| SGEN | Seattle Genetics, Inc. | -3.59% | 111.24 | 6.1% | $163.42m | |
| NVAX | Novavax, Inc. | 3.31% | 14.03 | 114.7% | $128.96m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | -3.96% | 104.54 | 8.7% | $98.37m |
Company Profile
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development and commercialization of proprietary therapeutics. Its portfolio includes compounds in various stages, ranging from preclinical to late stage development, and commercialized products such as JAKAFI (ruxolitinib), and ICLUSIG (ponatinib). The company was founded by Roy A. Whitfield in April 1991 and is headquartered in Wilmington, DE.